Company registration number 03727566 (England and Wales)
CARE WORLDWIDE LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
CARE WORLDWIDE LIMITED
COMPANY INFORMATION
Directors
A Goldstein
A L Levison
Company number
03727566
Registered office
1st Floor, Cloister House
Riverside
New Bailey Street
Manchester
M3 5FS
Auditor
Lopian Gross Barnett & Co
1st Floor, Cloister House
Riverside
New Bailey Street
Manchester
M3 5FS
Business address
Bondcare House
18 Lodge Road
London
NW4 4EF
CARE WORLDWIDE LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3 - 5
Directors' responsibilities statement
6
Independent auditor's report
7 - 9
Profit and loss account
10
Group statement of comprehensive income
11
Group balance sheet
12
Company balance sheet
13
Group statement of changes in equity
14
Company statement of changes in equity
15
Group statement of cash flows
16
Notes to the financial statements
17 - 33
CARE WORLDWIDE LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 1 -

The directors present the strategic report for the year ended 31 December 2025.

Review of the business

The principal activities of the companies in the group during the current and previous year s were that of operating residential and nursing homes, caring for the elderly, as well as residents with dementia and disabilities.

The group has continued to maintain its excellent high standard provision of service maintaining the occupancy levels at all the homes resulting in improved financial performance during the year. The consolidated profit and loss account on page 10 shows a group turnover of £42,726,674 (2024; £35,177,513) and group operating profit of £6,088,844 (2024: £5,484,756), after charitable donations made by the group of £1,748,270 (2024: £748,554). The group s profit after tax for the year amounted to £3,177,422 (2024: £2,504,816).

Principal risks and uncertainties

The director considers the group is not significantly exposed to price and credit risks since the majority of the Care home revenue is derived from publicly funded authorities. The director considers that the high quality of care that each of the homes in the group provides stands the group in an excellent position and secures its ongoing trading position against any possible risks and uncertainties.

Development and performance

The position of the group at the balance sheet date remains strong and in line with the director's expectations.

Key performance indicators

The group monitors cash flow as part of its day to day control procedures. Current cash position and future cash requirements are closely tracked to ensure appropriate facilities are available as and when required.

Other financial key performance indicators include turnover, gross profit margin, EBITDA and loan cover. EBITDA after adjustments for one off exceptional costs is considered the strongest indicator of cash generation from the business. Adjusted EBITDA for the year amounted to £9,382,564 (2024: £7,568,135).

Other performance indicators

Other key performance indicators include home occupancy levels, charge rates, staffing hours and changes to rates of pay.

Section 172(1) Statement

The Directors of the company have acted in accordance with their duties codified in law, which include their duty to act in a way which they consider, in good faith, would most likely promote the success of the Company for the benefit of the members as a whole, having regards to all stakeholders and matters set out in s172(1) of the Companies Act 2016, including:

(a) the likely consequences of any decision in the long term;

(b) the interests of the company's employees;

(c) the need to foster the company's business relationships with suppliers, customers and others;

(d) the impact of the company's operations on the community and the environment;

(e) the desirability of the company maintaining a reputation for high standards of business conduct; and

(f) the need to act fairly as between members of the company.

CARE WORLDWIDE LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -

The directors make decisions by taking their legal duty into account and the priorities and requirements of the stakeholders.

The directors have regard to the likely consequences of their decisions on the long-term objectives and sustainability of the group, its stakeholders and the community whilst also preserving its values and culture. With this in mind, when a dividend is proposed it is important to confirm the availability of distributable reserves whilst also considering cash requirements for future investment and without prejudicing the position of other creditors. We are a business built on our standards and reputation and would not take a decision which would have a detrimental impact on this whether in the short term or the long term. We are dedicated to ensuring we maintain our culture whilst achieving our purpose.

Our employees are key so it is very important that they have the right attitude and the drive to create ideas, obtain and sustain high standards. All employees are encouraged to be honest and regular discussions are held with employees which gives them the opportunity to air their ideas and the directors can then see first-hand where any improvements can be made.

We carry out our business with similar-minded and reputable people, and build on this to forge strong and lasting partnerships which is important for our long-term success.

On behalf of the board

A Goldstein
Director
1 July 2026
CARE WORLDWIDE LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -

The directors present their annual report and financial statements for the year ended 31 December 2025.

Principal activities

The principal activity of the company and group continued to be that of operating residential and nursing homes, caring for the elderly, as well as residents with dementia and disabilities.

Results and dividends

The results for the year are set out on page 10.

No ordinary dividends were paid. The directors do not recommend payment of a further dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

A Goldstein
A L Levison
Financial instruments
Liquidity risk

The group manages its cash and borrowing requirements in order to maximise interest income and minimise interest expense, whilst ensuring the group has sufficient liquid resources to meet the operating needs of the business.

Interest rate risk

The group is exposed to fair value interest rate risk on its fixed rate borrowings and cash flow interest rate risk on floating rate deposits, bank overdrafts and loans. The group uses interest rate derivatives to manage the mix of fixed and variable rate debt so as to reduce its exposure to changes in interest rates.

Credit risk

Investments of cash surpluses, borrowings and derivative instruments are made through banks and companies which must fulfil credit rating criteria approved by the Board.

Trade debtors are monitored on an ongoing basis and provision is made for doubtful debts where necessary.

Disabled persons

The group's policy is to recruit disabled workers for those vacancies that they are able to fill. All necessary assistance with initial training courses is given. Once employed, a career plan is developed so as to ensure suitable opportunities for each disabled person. Arrangements are made, wherever possible, for retraining employees who become disabled, to enable them to perform work identified as appropriate to their aptitudes and abilities.

Employee involvement

The group's policy is to have the management team visit homes, consult and discuss matters of current interest and concern to the business with employees.

Information about matters of concern to employees is given through information bulletins and reports which seek to achieve a common awareness on the part of all employees of the financial and economic factors affecting the company's performance.

Auditor

In accordance with the company's articles, a resolution proposing that Lopian Gross Barnett & Co be reappointed as auditor of the group will be put at a General Meeting.

CARE WORLDWIDE LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 4 -
Energy and carbon report
2025
2024
Energy consumption
kWh
kWh
Aggregate of energy consumption in the year
- Gas combustion
3,308,152
3,504,549
- Electricity purchased
1,096,608
1,054,039
- Fuel consumed for transport
16,000
16,000
4,420,760
4,574,588
2025
2024
Emissions of CO2 equivalent
metric tonnes
metric tonnes
Scope 1 - direct emissions
- Gas combustion
611.00
640.98
- Fuel consumed for owned transport
4.00
4.00
615.00
644.98
Scope 2 - indirect emissions
- Electricity purchased
194.00
218.24
Scope 3 - other indirect emissions
- Fuel consumed for transport not owned by the
-
-
Total gross emissions
809.00
863.22
Intensity ratio
Tonnes Co2e per carehome bed
1.65
1.85
Quantification and reporting methodology

The group has followed the 2019 HM Government Environmental Reporting Guidelines. The group has also used the GHG Reporting Protocol – Corporate Standard and have used the 2020 UK Government’s Conversion Factors for Company Reporting

Intensity measurement

The chosen intensity measurement ratio is total gross emissions in metric tonnes CO2e per carehome bed.

Measures taken to improve energy efficiency

We constantly monitor energy usage within the carehomes and encourage and educate all staff in efficient usage.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.

CARE WORLDWIDE LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
On behalf of the board
A Goldstein
Director
1 July 2026
CARE WORLDWIDE LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 6 -

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

United Kingdom company law requires the directors to prepare financial statements for each financial year. Under that law, the directors have elected to prepare the group and parent company financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and parent company, and of the profit or loss of the group for that period.

In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;

- make judgements and accounting estimates that are reasonable and prudent;

- state whether applicable U nited K ingdom Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the group and parent company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and parent company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and parent company, and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and parent company, and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

CARE WORLDWIDE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF CARE WORLDWIDE LIMITED
- 7 -
Opinion

We have audited the financial statements of Care Worldwide Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2025 which comprise the group profit and loss account, the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

- give a true and fair view of the state of the group's and the parent company's affairs as at 31 December 2025 and of the group's profit for the year then ended;

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

- have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

- T he information given in the strategic report and the directors' r eport for the financial year for which the financial statements are prepared is consistent with the financial statements; and

- The strategic report and the directors' report have been prepared in accordance with applicable legal requirements.

CARE WORLDWIDE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF CARE WORLDWIDE LIMITED
- 8 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent company and their environment obtained in the course of the audit, we have not identifie d material misstatements in the strategic report or the directors' r eport.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

- adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or

- the parent company financial statements are not in agreement with the accounting records and returns; or

- certain disclosures of directors' remuneration specified by law are not made; or

- we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the directors' r esponsibilities s tatement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the group's and parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or parent company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below:

- We obtained an understanding of laws and regulations that affect the entity, focusing on those that had a direct effect on the financial statements or that had a fundamental effect on its operations.

- Where considered necessary we enquired of those charged with governance, reviewed correspondence and reviewed meeting minutes for evidence of non-compliance with relevant laws and regulations.

- We gained an understanding of the controls environment which includes the controls in place to prevent and detect fraud. We enquired of those charged with governance about any incidences of fraud that had taken place during the accounting period.

- The risk of fraud and non-compliance with laws and regulations was discussed within the audit team and tests were planned and performed to address these risks.

- We reviewed financial statements disclosures to assess compliance with relevant laws and regulations.

- We enquired of those charged with governance about actual and potential litigation and claims.

- We performed analytical procedures to identify any unusual or unexpected relationships that might indicate risks of material misstatement due to fraud.

CARE WORLDWIDE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF CARE WORLDWIDE LIMITED
- 9 -

- In addressing the risk of fraud due to management override of internal controls we tested the appropriateness of journal entries and assessed whether the judgements made in making accounting estimates were indicative of a potential bias.

Due to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements, even though we have properly planned and performed our audit in accordance with auditing standards. For example, as with any audit, there remained a higher risk of non-detection of irregularities, as these may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal controls. We are not responsible for preventing fraud or non-compliance with laws and regulations and cannot be expected to detect all fraud and non-compliance with laws and regulations.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the parent company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the parent company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the parent company and the parent company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Jonathan Brodie FCA (Senior Statutory Auditor)
For and on behalf of Lopian Gross Barnett & Co, Statutory Auditor
Chartered Accountants
1st Floor, Cloister House
Riverside
New Bailey Street
Manchester
M3 5FS
1 July 2026
CARE WORLDWIDE LIMITED
GROUP PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 10 -
2025
2024
Notes
£
£
Turnover
3
42,726,674
35,177,513
Cost of sales
(29,389,178)
(23,834,224)
Gross profit
13,337,496
11,343,289
Administrative expenses
(7,248,652)
(5,860,459)
Other operating income
-
0
1,926
Operating profit
4
6,088,844
5,484,756
Interest receivable and similar income
7
23,646
28,304
Interest payable and similar expenses
8
(1,715,218)
(1,786,350)
Profit before taxation
4,397,272
3,726,710
Tax on profit
9
(1,219,850)
(1,221,894)
Profit for the financial year
3,177,422
2,504,816
Profit for the financial year is all attributable to the owners of the parent company.

The profit and loss account has been prepared on the basis that all operations are continuing operations.

CARE WORLDWIDE LIMITED
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2025
- 11 -
2025
2024
£
£
Profit for the year
3,177,422
2,504,816
Other comprehensive income
-
-
Cash flow hedges gain arising in the year
-
0
-
0
Total comprehensive income for the year
3,177,422
2,504,816
Total comprehensive income for the year is all attributable to the owners of the parent company.
CARE WORLDWIDE LIMITED
GROUP BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 12 -
2025
2024
Notes
£
£
£
£
Fixed assets
Goodwill
10
715,943
775,193
Total intangible assets
715,943
775,193
Tangible assets
11
31,236,831
29,340,859
31,952,774
30,116,052
Current assets
Debtors
14
31,750,380
25,627,185
Cash at bank and in hand
1,627,539
1,451,807
33,377,919
27,078,992
Creditors: amounts falling due within one year
16
(20,141,863)
(15,235,277)
Net current assets
13,236,056
11,843,715
Total assets less current liabilities
45,188,830
41,959,767
Creditors: amounts falling due after more than one year
17
(23,856,250)
(23,759,167)
Provisions for liabilities
Deferred tax liability
19
1,055,275
1,100,717
(1,055,275)
(1,100,717)
Net assets
20,277,305
17,099,883
Capital and reserves
Called up share capital
22
603
603
Other reserves
4,597,607
4,597,607
Profit and loss reserves
15,679,095
12,501,673
Total equity
20,277,305
17,099,883
The financial statements were approved by the board of directors and authorised for issue on 1 July 2026 and are signed on its behalf by:
01 July 2026
A Goldstein
Director
Company registration number 03727566 (England and Wales)
CARE WORLDWIDE LIMITED
COMPANY BALANCE SHEET
AS AT 31 DECEMBER 2025
31 December 2025
- 13 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
11
23,994
17,492
Investments
12
704
704
24,698
18,196
Current assets
Debtors
14
33,122,072
26,628,479
Cash at bank and in hand
570,388
610,094
33,692,460
27,238,573
Creditors: amounts falling due within one year
16
(20,740,861)
(10,027,873)
Net current assets
12,951,599
17,210,700
Total assets less current liabilities
12,976,297
17,228,896
Creditors: amounts falling due after more than one year
17
(23,856,250)
(23,759,167)
Net liabilities
(10,879,953)
(6,530,271)
Capital and reserves
Called up share capital
22
603
603
Profit and loss reserves
(10,880,556)
(6,530,874)
Total equity
(10,879,953)
(6,530,271)

As permitted by s408 Companies Act 2006, the c ompany has not presented its own profit and loss account and related notes. The c ompany’s loss for the year was £4,349,682 (2024 - £3,457,333 loss).

The financial statements were approved by the board of directors and authorised for issue on 1 July 2026 and are signed on its behalf by:
01 July 2026
A Goldstein
Director
Company registration number 03727566 (England and Wales)
CARE WORLDWIDE LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
- 14 -
Share capital
Merger reserves
Profit and loss reserves
Total
£
£
£
£
Balance at 1 January 2024
603
4,597,607
9,996,857
14,595,067
Year ended 31 December 2024:
Profit and total comprehensive income for the year
-
-
2,504,816
2,504,816
Balance at 31 December 2024
603
4,597,607
12,501,673
17,099,883
Year ended 31 December 2025:
Profit and total comprehensive income for the year
-
-
3,177,422
3,177,422
Balance at 31 December 2025
603
4,597,607
15,679,095
20,277,305
CARE WORLDWIDE LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
- 15 -
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 January 2024
603
(3,073,541)
(3,072,938)
Year ended 31 December 2024:
Loss and total comprehensive income for the year
-
(3,457,333)
(3,457,333)
Balance at 31 December 2024
603
(6,530,874)
(6,530,271)
Year ended 31 December 2025:
Profit and total comprehensive income
-
(4,349,682)
(4,349,682)
Balance at 31 December 2025
603
(10,880,556)
(10,879,953)
CARE WORLDWIDE LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 16 -
2025
2024
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
25
6,049,563
7,676,342
Interest paid
(1,715,218)
(1,786,350)
Income taxes paid
(1,411,202)
(1,343,207)
Net cash inflow from operating activities
2,923,143
4,546,785
Investing activities
Purchase of tangible fixed assets
(3,006,187)
(5,675,548)
Interest received
23,646
28,304
Net cash used in investing activities
(2,982,541)
(5,647,244)
Financing activities
Proceeds from new bank loans
2,100,000
2,925,000
Repayment of bank loans
(1,862,916)
(1,716,667)
Net cash generated from financing activities
237,084
1,208,333
Net increase in cash and cash equivalents
177,686
107,874
Cash and cash equivalents at beginning of year
1,449,853
1,341,979
Cash and cash equivalents at end of year
1,627,539
1,449,853
Relating to:
Cash at bank and in hand
1,627,539
1,451,807
Bank overdrafts included in creditors payable within one year
-
(1,954)
CARE WORLDWIDE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 17 -
1
Accounting policies
Company information

Care Worldwide Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is 1st Floor, Cloister House, Riverside, New Bailey Street, Manchester, M3 5FS.

The group consists of Care Worldwide Limited and all of its subsidiaries.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements:

- Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;

- Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.

1.2
Business combinations

In the parent company financial statements, t he cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill. The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date. Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date. I nvestments in subsidiaries, joint ventures and associates are accounted for at cost less impairment.

Deferred tax is recognised on differences between the value of assets (other than goodwill) and liabilities recognised in a business combination accounted for using the purchase method and the amounts that can be deducted or assessed for tax, considering the manner in which the carrying amount of the asset or liability is expected to be recovered or settled. The deferred tax recognised is adjusted against goodwill or negative goodwill.

CARE WORLDWIDE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 18 -
1.3
Basis of consolidation

The consolidated group financial statements consist of the financial statements of the parent company Care Worldwide Limited together with all entities controlled by the parent company (its subsidiaries) and the group’s share of its interests in joint ventures and associates.

All financial statements are made up to 31 December 2025. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the g roup.

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

Entities in which the group holds an interest and which are jointly controlled by the group and one or more other venturers under a contractual arrangement are treated as joint ventures. Entities other than subsidiary undertakings or joint ventures, in which the group has a participating interest and over whose operating and financial policies the group exercises a significant influence, are treated as associates.

Investments in joint ventures and associates are carried in the group balance sheet at cost plus post-acquisition changes in the group’s share of the net assets of the entity, less any impairment in value. The carrying values of investments in joint ventures and associates include acquired goodwill.

If the group’s share of losses in a joint venture or associate equals or exceeds its investment in the joint venture or associate, the group does not recognise further losses unless it has incurred obligations to do so or has made payments on behalf of the joint venture or associate.

Unrealised gains arising from transactions with joint ventures and associates are eliminated to the extent of the group’s interest in the entity.

1.4
Going concern

The company is supported by its ultimate parent by way of loans. T he director has received assurances that this support will continue and on that basis consider s it appropriate to prepare the financial statements on the going concern basis. The financial statements do not include any adjustments that would result from a withdrawal of th is support.

1.5
Revenue

Turnover represents amounts receivable for goods and services.

Revenue represents income receivable from health and care provision services rendered and goods supplied. Revenue is stated net of value added taxation and other sales taxes, rebates and discount. Revenue is recognised in the accounting period in which the company obtains the right to consideration in exchange for its performance.

CARE WORLDWIDE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 19 -
1.6
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of a business over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 20 years.

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.7
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings Freehold
2% Straight line
Fixtures, fittings & equipment
15%-20% Staright line/Reducing balance
Motor vehicles
25% Straight line/Reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.

1.8
Fixed asset investments

Equity in vest ments are measured at fair value through profit or loss, except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably, which are recognised at cost less impairment until a reliable measure of fair value becomes available.

I n the parent company financial statements, investments in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.

A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

CARE WORLDWIDE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 20 -

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The group considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Investments in associates are initially recognised at the transaction price (including transaction costs) and are subsequently adjusted to reflect the g roup’s share of the profit or loss, other comprehensive income and equity of the associate using the equity method. Any difference between the cost of acquisition and the share of the fair value of the net identifiable assets of the associate on acquisition is recognised as goodwill. Any unamortised balance of goodwill is included in the carrying value of the investment in associates.

Losses in excess of the carrying amount of an investment in an associate are recorded as a provision only when the company has incurred legal or constructive obligations or has made payments on behalf of the associate.

In the parent c ompany financial statements, investments in associates are accounted for at cost less impairment.

Entities in which the group has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.9
Impairment of fixed assets

At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

The carrying amount of the investments accounted for using the equity method is tested for impairment as a single asset. Any goodwill included in the carrying amount of the investment is not tested separately for impairment.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.10
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

CARE WORLDWIDE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 21 -
1.11
Financial instruments

The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the group's balance sheet when the group becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest m ethod unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.

CARE WORLDWIDE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 22 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value th r ough profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.

1.12
Equity instruments

Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.

1.13
Derivatives

Derivatives are initially recognised at fair value at the date a derivative contract is entered into and are subsequently remeasured to fair value at each reporting end date. The resulting gain or loss is recognised in profit or loss immediately unless the derivative is designated and effective as a hedging instrument, in which event the timing of the recognition in profit or loss depends on the nature of the hedge relationship.

A derivative with a positive fair value is recognised as a financial asset, whereas a derivative with a negative fair value is recognised as a financial liability.

1.14
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

CARE WORLDWIDE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 23 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.15
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.16
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.17
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease d asset are consumed.

1.18
Government grants

Government grants are recognised at the fair value of the asset receive d or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

1.19
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

CARE WORLDWIDE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 24 -
2
Judgements and key sources of estimation uncertainty

In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Turnover and other revenue

An analysis of the group's turnover is as follows:

2025
2024
£
£
Turnover analysed by class of business
Carehome activities
42,726,674
35,177,513
2025
2024
£
£
Turnover analysed by geographical market
UK activities
42,726,674
35,177,513
2025
2024
£
£
Other revenue
Interest income
23,646
28,304
Grants received
-
1,926
4
Operating profit
2025
2024
£
£
Operating profit for the year is stated after charging/(crediting):
Government grants
-
(1,926)
Depreciation of tangible fixed assets
1,110,215
1,039,864
Amortisation of intangible assets
59,250
59,250
Operating lease charges
529,537
418,522
CARE WORLDWIDE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 25 -
5
Auditor's remuneration
2025
2024
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the group and company
9,000
6,500
Audit of the financial statements of the company's subsidiaries
48,725
37,875
57,725
44,375
For other services
All other non-audit services
42,000
42,000
6
Employees

The average monthly number of persons (including directors) employed by the group and company during the year was:

Group
Company
2025
2024
2025
2024
Number
Number
Number
Number
Carehome staff
965
845
-
-
Head office administration
5
6
5
7
Total
970
851
5
7

Their aggregate remuneration comprised:

Group
Company
2025
2024
2025
2024
£
£
£
£
Wages and salaries
23,933,720
19,627,076
167,379
139,316
Social security costs
2,716,909
1,677,447
8,932
13,464
Pension costs
366,648
307,003
1,031
1,852
27,017,277
21,611,526
177,342
154,632
7
Interest receivable and similar income
2025
2024
£
£
Interest income
Interest on bank deposits
23,646
28,199
Other interest income
-
105
Total income
23,646
28,304
CARE WORLDWIDE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 26 -
8
Interest payable and similar expenses
2025
2024
£
£
Interest on bank overdrafts and loans
1,699,844
1,752,214
Other interest
15,374
34,136
Total finance costs
1,715,218
1,786,350
9
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
1,265,292
1,097,810
Deferred tax
Origination and reversal of timing differences
(45,442)
124,084
Total tax charge
1,219,850
1,221,894

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2025
2024
£
£
Profit before taxation
4,397,272
3,726,710
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
1,099,318
931,678
Tax effect of expenses that are not deductible in determining taxable profit
21,203
10,554
Unutilised tax losses carried forward
-
0
13,792
Permanent capital allowances in excess of depreciation
49,578
49,795
Depreciation on assets not qualifying for tax allowances
95,193
91,991
Deferred Tax
(45,442)
124,084
Taxation charge
1,219,850
1,221,894
CARE WORLDWIDE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 27 -
10
Intangible fixed assets
Group
Goodwill
£
Cost
At 1 January 2025 and 31 December 2025
1,185,005
Amortisation and impairment
At 1 January 2025
409,812
Amortisation charged for the year
59,250
At 31 December 2025
469,062
Carrying amount
At 31 December 2025
715,943
At 31 December 2024
775,193
The company had no intangible fixed assets at 31 December 2025 or 31 December 2024.
11
Tangible fixed assets
Group
Land and buildings Freehold
Fixtures, fittings & equipment
Motor vehicles
Total
£
£
£
£
Cost
At 1 January 2025
35,545,841
3,016,791
189,955
38,752,587
Additions
2,443,645
548,042
14,500
3,006,187
At 31 December 2025
37,989,486
3,564,833
204,455
41,758,774
Depreciation and impairment
At 1 January 2025
7,303,603
1,995,056
113,069
9,411,728
Depreciation charged in the year
738,855
348,598
22,762
1,110,215
At 31 December 2025
8,042,458
2,343,654
135,831
10,521,943
Carrying amount
At 31 December 2025
29,947,028
1,221,179
68,624
31,236,831
At 31 December 2024
28,242,238
1,021,735
76,886
29,340,859
CARE WORLDWIDE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
11
Tangible fixed assets
(Continued)
- 28 -
Company
Fixtures, fittings & equipment
Motor vehicles
Total
£
£
£
Cost
At 1 January 2025
46,519
9,800
56,319
Additions
-
0
14,500
14,500
At 31 December 2025
46,519
24,300
70,819
Depreciation and impairment
At 1 January 2025
30,482
8,345
38,827
Depreciation charged in the year
4,009
3,989
7,998
At 31 December 2025
34,491
12,334
46,825
Carrying amount
At 31 December 2025
12,028
11,966
23,994
At 31 December 2024
16,037
1,455
17,492
12
Fixed asset investments
Group
Company
2025
2024
2025
2024
Notes
£
£
£
£
Investments in subsidiaries
13
-
0
-
0
704
704
Movements in fixed asset investments
Company
Shares in subsidiaries
£
Cost or valuation
At 1 January 2025 and 31 December 2025
704
Carrying amount
At 31 December 2025
704
At 31 December 2024
704
CARE WORLDWIDE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 29 -
13
Subsidiaries

Details of the company's subsidiaries at 31 December 2025 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Care Worldwide (Carlton) Limited
1st Floor Cloister House, Riverside, New Bailey Street, Manchester, United Kingdom, M3 5FS
Ordinary
100.00
Care Worldwide (Devon) Limited
1st Floor Cloister House, Riverside, New Bailey Street, Manchester, United Kingdom, M3 5FS
Ordinary
100.00
Care Worldwide (Links) Limited
1st Floor Cloister House, Riverside, New Bailey Street, Manchester, United Kingdom, M3 5FS
Ordinary
100.00
Care Worldwide (London) Limited
1st Floor Cloister House, Riverside, New Bailey Street, Manchester, United Kingdom, M3 5FS
Ordinary
100.00
Care Worldwide (Manchester) Limited
1st Floor Cloister House, Riverside, New Bailey Street, Manchester, United Kingdom, M3 5FS
Ordinary
100.00
Care Worldwide (Oldham) Limited
1st Floor Cloister House, Riverside, New Bailey Street, Manchester, United Kingdom, M3 5FS
Ordinary
100.00
Care Worldwide (Southwell) Limited
1st Floor Cloister House, Riverside, New Bailey Street, Manchester, United Kingdom, M3 5FS
Ordinary
100.00
Care Worldwide (Staffordshire) Limited
1st Floor Cloister House, Riverside, New Bailey Street, Manchester, United Kingdom, M3 5FS
Ordinary
100.00
Care Worldwide (Wednesbury) Limited
1st Floor Cloister House, Riverside, New Bailey Street, Manchester, United Kingdom, M3 5FS
Ordinary
100.00
Care Worldwide (Ramsey) Limited
1st Floor Cloister House, Riverside, New Bailey Street, Manchester, United Kingdom, M3 5FS
Ordinary
100.00
Care Worldwide (Bexhill) Limited
1st Floor Cloister House, Riverside, New Bailey Street, Manchester, United Kingdom, M3 5FS
Ordinary
100.00
14
Debtors
Group
Company
2025
2024
2025
2024
Amounts falling due within one year:
£
£
£
£
Trade debtors
3,807,101
2,988,157
14,615
90,351
Corporation tax recoverable
92,228
144,362
-
0
-
0
Amounts owed by group undertakings
18,136,035
14,414,615
24,976,974
19,802,423
Other debtors
9,098,507
7,392,449
7,843,242
6,434,233
Prepayments and accrued income
616,509
687,602
287,241
301,472
31,750,380
25,627,185
33,122,072
26,628,479

Within amounts owed by group undertakings includes an amount owed by ultimate parent company of £18,136,035(2024: £14,414,615).

CARE WORLDWIDE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 30 -
15
Financial instruments
Group
Company
2025
2024
2025
2024
£
£
£
£
Carrying amount of financial assets
Debt instruments measured at amortised cost
31,089,444
24,846,221
n/a
n/a
Carrying amount of financial liabilities
Measured at amortised cost
43,058,893
38,059,667
n/a
n/a
16
Creditors: amounts falling due within one year
Group
Company
2025
2024
2025
2024
Notes
£
£
£
£
Bank loans and overdrafts
18
2,051,667
1,913,620
2,051,667
1,911,666
Trade creditors
1,022,288
700,069
12,682
-
0
Amounts owed to group undertakings
-
0
-
0
10,917,901
4,080,697
Corporation tax payable
275,413
473,457
-
0
-
0
Other taxation and social security
661,060
461,320
21,131
25,173
Deferred income
20
2,747
-
0
-
0
-
0
Other creditors
12,373,958
8,488,955
7,689,902
3,958,636
Accruals and deferred income
3,754,730
3,197,856
47,578
51,701
20,141,863
15,235,277
20,740,861
10,027,873
17
Creditors: amounts falling due after more than one year
Group
Company
2025
2024
2025
2024
Notes
£
£
£
£
Bank loans and overdrafts
18
23,856,250
23,759,167
23,856,250
23,759,167
18
Loans and overdrafts
Group
Company
2025
2024
2025
2024
£
£
£
£
Bank loans
25,907,917
25,670,833
25,907,917
25,670,833
Bank overdrafts
-
0
1,954
-
0
-
0
25,907,917
25,672,787
25,907,917
25,670,833
Payable within one year
2,051,667
1,913,620
2,051,667
1,911,666
Payable after one year
23,856,250
23,759,167
23,856,250
23,759,167
CARE WORLDWIDE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
18
Loans and overdrafts
(Continued)
- 31 -

In 2023, the group refinanced it's bank sterling term facility loan of £25,750,000 with a termination date being the fifth anniversary of the utilisation date. Repayment is by way of quarterly repayments based on a 15 year repayment profile with the balance repayable on the termination date. The group increased its term facility by £2,925,000 during the year ended 31 December 2024.

During the current year, the group increased its bank sterling term facility by an further £2,100,000, bringing the total facility to £30,775,000. The terms and repayment schedule of the loan remain unchanged, with repayment continuing on a quarterly basis, based on the original 15-year repayment profile. The termination date is set for the fifth anniversary of the original utilisation date, with the outstanding balance repayable on that date

The loan is secured by composite debenture incorporating mortgages over each of the properties owned by the company and share charges over subsidiaries.

The rate of interest on the loan for each interest period is the percentage rate per annum which is aggregate of the applicable margin of 2.4% plus Bank of England Base Rate.

19
Deferred taxation

Deferred tax assets and liabilities are offset where the group or company has a legally enforceable right to do so. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:

Liabilities
Liabilities
2025
2024
Group
£
£
Accelerated capital allowances
221,507
181,903
Revaluations - Property
833,768
918,814
1,055,275
1,100,717
The company has no deferred tax assets or liabilities.
Group
Company
2025
2025
Movements in the year:
£
£
Liability at 1 January 2025
1,100,717
-
Credit to profit or loss
(45,442)
-
Liability at 31 December 2025
1,055,275
-
CARE WORLDWIDE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 32 -
20
Deferred income
Group
Company
2025
2024
2025
2024
£
£
£
£
Other deferred income
2,747
-
-
-
21
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
366,648
307,003

A defined contribution pension scheme is operated for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund.

22
Share capital
Group and company
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
603
603
603
603
23
Related party transactions
Transactions with related parties

The following amounts were outstanding at the reporting end date:

Amounts due to related parties
2025
2024
£
£
Group
Connected party loans (interest free)
10,573,070
5,785,176
Company
Connected party loans (interest free)
7,537,599
3,845,975

The following amounts were outstanding at the reporting end date:

Amounts due from related parties
2025
2024
Balance
Balance
£
£
Group
Connected party loans (interest free)
24,465,120
20,275,422
CARE WORLDWIDE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
23
Related party transactions
(Continued)
- 33 -
Company
Connected party loans (interest free)
24,523,891
20,381,389
24
Controlling party

The ultimate controlling parties are Mr Alan Goldstein and Mrs Sarah Goldstein.

25
Cash generated from group operations
2025
2024
£
£
Profit after taxation
3,177,422
2,504,816
Adjustments for:
Taxation charged
1,219,850
1,221,894
Finance costs
1,715,218
1,786,350
Investment income
(23,646)
(28,304)
Amortisation and impairment of intangible assets
59,250
59,250
Depreciation and impairment of tangible fixed assets
1,110,215
1,039,864
Movements in working capital:
Increase in debtors
(6,175,329)
(2,943,207)
Increase in creditors
4,963,836
4,035,679
Increase in deferred income
2,747
-
Cash generated from operations
6,049,563
7,676,342
26
Analysis of changes in net debt - group
1 January 2025
Cash flows
31 December 2025
£
£
£
Cash at bank and in hand
1,451,807
175,732
1,627,539
Bank overdrafts
(1,954)
1,954
-
0
1,449,853
177,686
1,627,539
Borrowings excluding overdrafts
(25,670,833)
(237,084)
(25,907,917)
(24,220,980)
(59,398)
(24,280,378)
2025-12-31 2025-01-01 false false CCH Software CCH Accounts Production 2026.100 A Goldstein A L Levison false 03727566 bus:Consolidated 2025-01-01 2025-12-31 03727566 2025-01-01 2025-12-31 03727566 bus:Director1 2025-01-01 2025-12-31 03727566 bus:Director2 2025-01-01 2025-12-31 03727566 bus:RegisteredOffice 2025-01-01 2025-12-31 03727566 core:CapitalRedemptionReserve 2023-12-31 03727566 core:OtherMiscellaneousReserve 2023-12-31 03727566 core:ShareCapital bus:Consolidated 2025-12-31 03727566 core:ShareCapital bus:Consolidated 2024-12-31 03727566 core:OtherMiscellaneousReserve bus:Consolidated 2025-12-31 03727566 core:OtherMiscellaneousReserve bus:Consolidated 2024-12-31 03727566 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2025-12-31 03727566 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2024-12-31 03727566 bus:Consolidated 2025-12-31 03727566 bus:Consolidated 2024-12-31 03727566 core:ShareCapital 2025-12-31 03727566 core:ShareCapital 2024-12-31 03727566 core:RetainedEarningsAccumulatedLosses 2025-12-31 03727566 core:RetainedEarningsAccumulatedLosses 2024-12-31 03727566 2025-12-31 03727566 2024-12-31 03727566 core:ShareCapital bus:Consolidated 2023-12-31 03727566 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2023-12-31 03727566 core:ShareCapital 2023-12-31 03727566 core:RetainedEarningsAccumulatedLosses 2023-12-31 03727566 bus:Consolidated 2024-01-01 2024-12-31 03727566 2024-01-01 2024-12-31 03727566 core:Goodwill bus:Consolidated 2025-12-31 03727566 core:Goodwill bus:Consolidated 2024-12-31 03727566 core:LandBuildings core:OwnedOrFreeholdAssets bus:Consolidated 2025-12-31 03727566 core:FurnitureFittings bus:Consolidated 2025-12-31 03727566 core:MotorVehicles bus:Consolidated 2025-12-31 03727566 core:LandBuildings core:OwnedOrFreeholdAssets bus:Consolidated 2024-12-31 03727566 core:FurnitureFittings bus:Consolidated 2024-12-31 03727566 core:MotorVehicles bus:Consolidated 2024-12-31 03727566 core:FurnitureFittings 2025-12-31 03727566 core:MotorVehicles 2025-12-31 03727566 core:FurnitureFittings 2024-12-31 03727566 core:MotorVehicles 2024-12-31 03727566 core:CurrentFinancialInstruments core:WithinOneYear bus:Consolidated 2025-12-31 03727566 core:CurrentFinancialInstruments bus:Consolidated 2024-12-31 03727566 core:CurrentFinancialInstruments core:WithinOneYear bus:Consolidated 2024-12-31 03727566 core:Non-currentFinancialInstruments core:AfterOneYear 2025-12-31 03727566 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 03727566 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 03727566 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 03727566 bus:Consolidated 2023-12-31 03727566 core:Goodwill 2025-01-01 2025-12-31 03727566 core:LandBuildings core:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 03727566 core:FurnitureFittings 2025-01-01 2025-12-31 03727566 core:MotorVehicles 2025-01-01 2025-12-31 03727566 core:UKTax bus:Consolidated 2025-01-01 2025-12-31 03727566 core:UKTax bus:Consolidated 2024-01-01 2024-12-31 03727566 bus:Consolidated 1 2025-01-01 2025-12-31 03727566 bus:Consolidated 1 2024-01-01 2024-12-31 03727566 core:Goodwill bus:Consolidated 2024-12-31 03727566 core:Goodwill bus:Consolidated 2025-01-01 2025-12-31 03727566 core:LandBuildings core:OwnedOrFreeholdAssets bus:Consolidated 2024-12-31 03727566 core:FurnitureFittings bus:Consolidated 2024-12-31 03727566 core:MotorVehicles bus:Consolidated 2024-12-31 03727566 bus:Consolidated 2024-12-31 03727566 core:FurnitureFittings 2024-12-31 03727566 core:MotorVehicles 2024-12-31 03727566 2024-12-31 03727566 core:LandBuildings core:OwnedOrFreeholdAssets bus:Consolidated 2025-01-01 2025-12-31 03727566 core:FurnitureFittings bus:Consolidated 2025-01-01 2025-12-31 03727566 core:MotorVehicles bus:Consolidated 2025-01-01 2025-12-31 03727566 core:Subsidiary1 2025-01-01 2025-12-31 03727566 core:Subsidiary2 2025-01-01 2025-12-31 03727566 core:Subsidiary3 2025-01-01 2025-12-31 03727566 core:Subsidiary4 2025-01-01 2025-12-31 03727566 core:Subsidiary5 2025-01-01 2025-12-31 03727566 core:Subsidiary6 2025-01-01 2025-12-31 03727566 core:Subsidiary7 2025-01-01 2025-12-31 03727566 core:Subsidiary8 2025-01-01 2025-12-31 03727566 core:Subsidiary9 2025-01-01 2025-12-31 03727566 core:Subsidiary10 2025-01-01 2025-12-31 03727566 core:Subsidiary11 2025-01-01 2025-12-31 03727566 core:Subsidiary1 1 2025-01-01 2025-12-31 03727566 core:Subsidiary2 2 2025-01-01 2025-12-31 03727566 core:Subsidiary3 3 2025-01-01 2025-12-31 03727566 core:Subsidiary4 4 2025-01-01 2025-12-31 03727566 core:Subsidiary5 5 2025-01-01 2025-12-31 03727566 core:Subsidiary6 6 2025-01-01 2025-12-31 03727566 core:Subsidiary7 7 2025-01-01 2025-12-31 03727566 core:Subsidiary8 8 2025-01-01 2025-12-31 03727566 core:Subsidiary9 9 2025-01-01 2025-12-31 03727566 core:Subsidiary10 10 2025-01-01 2025-12-31 03727566 core:Subsidiary11 11 2025-01-01 2025-12-31 03727566 core:CurrentFinancialInstruments bus:Consolidated 2025-12-31 03727566 core:CurrentFinancialInstruments 2025-12-31 03727566 core:CurrentFinancialInstruments 2024-12-31 03727566 core:CurrentFinancialInstruments bus:Consolidated 1 2025-12-31 03727566 core:CurrentFinancialInstruments bus:Consolidated 1 2024-12-31 03727566 core:CurrentFinancialInstruments 2 2025-12-31 03727566 core:CurrentFinancialInstruments 2 2024-12-31 03727566 core:WithinOneYear bus:Consolidated 2025-12-31 03727566 core:WithinOneYear bus:Consolidated 2024-12-31 03727566 core:Non-currentFinancialInstruments core:AfterOneYear bus:Consolidated 2025-12-31 03727566 core:Non-currentFinancialInstruments core:AfterOneYear bus:Consolidated 2024-12-31 03727566 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 03727566 bus:FRS102 2025-01-01 2025-12-31 03727566 bus:Audited 2025-01-01 2025-12-31 03727566 bus:ConsolidatedGroupCompanyAccounts 2025-01-01 2025-12-31 03727566 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP